These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6394682)

  • 1. Critical evaluation of the existence of so-called tissue-bound lithocholate in human liver tissue by selected ion monitoring.
    Yanagisawa J; Akashi Y; Miyazaki H; Nakayama F
    J Lipid Res; 1984 Nov; 25(11):1263-71. PubMed ID: 6394682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithocholate in liver tissue with obstructive jaundice.
    Yanagisawa J; Nagai M; Hirano Y; Fujii T; Nakayama F
    Gastroenterol Jpn; 1989 Apr; 24(2):156-8. PubMed ID: 2744331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, physical and biological properties of lithocholyl-lysyl-fluorescein: a fluorescent monohydroxy bile salt analogue with cholestatic properties.
    Mills CO; Milkiewicz P; Molloy DP; Baxter DJ; Elias E
    Biochim Biophys Acta; 1997 Oct; 1336(3):485-96. PubMed ID: 9367176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids in tissues: binding of lithocholic acid to protein.
    Nair PP; Solomon R; Bankoski J; Plapinger R
    Lipids; 1978 Dec; 13(12):966-78. PubMed ID: 750835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
    Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
    Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of tissue-bound lithocholic acid and its implications in the role of bile acids in carcinogenesis.
    Turjman N; Nair PP
    Cancer Res; 1981 Sep; 41(9 Pt 2):3761-3. PubMed ID: 7020935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaffirmation of the validity of enzymatic cleavage of lithocholic acid from N-epsilon-lithocholyl-L-lysine and N-alpha-CBZ-N-epsilon-lithocholyl-L-lysine.
    Nair PP; Kessie G; Flanagan VP
    J Lipid Res; 1986 Aug; 27(8):905-9. PubMed ID: 2877042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of N-epsilon-lithocholyl-L-lysine, a component of tissue-bound lithocholic acid, via lithocholyl-N-hydroxysuccinimide.
    Nair PP; Kessie G; Turjman N
    J Steroid Biochem; 1985 Nov; 23(5A):573-6. PubMed ID: 4079375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithocholate glucuronide is a cholestatic agent.
    Oelberg DG; Chari MV; Little JM; Adcock EW; Lester R
    J Clin Invest; 1984 Jun; 73(6):1507-14. PubMed ID: 6547150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of taurine on the cholestatic potential of sulfated lithocholate and its conjugates.
    Belli DC; Roy CC; Fournier LA; Tuchweber B; Giguère R; Yousef IM
    Liver; 1991 Jun; 11(3):162-9. PubMed ID: 1886461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced biliary excretion of lithocholate-3-sulfate by ursodeoxycholate-3,7-disulfate infusion in Eisai hyperbilirubinemic rat (EHBR).
    Takikawa H; Sano N; Ogasawara T; Yamanaka M
    Dig Dis Sci; 1998 Jan; 43(1):188-92. PubMed ID: 9508524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives.
    Cowen AE; Korman MG; Hofmann AF; Thomas PJ
    Gastroenterology; 1975 Jul; 69(1):77-82. PubMed ID: 1150037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radioimmunoassay for lithocholic acid conjugates in human serum and liver tissue.
    Roda A; Roda E; Festi D; Aldini R; Mazzella G; Sama C; Barbara L
    Steroids; 1978; 32(1):13-24. PubMed ID: 705815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholestasis induced by lithocholate and its glucuronide: their biliary excretion and metabolism.
    Takikawa H; Ohki H; Sano N; Kasama T; Yamanaka M
    Biochim Biophys Acta; 1991 Jan; 1081(1):39-44. PubMed ID: 1991154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation.
    Allan RN; Thistle JL; Hofmann AF
    Gut; 1976 Jun; 17(6):413-9. PubMed ID: 955496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatic and extrahepatic glutathione S-transferases by primary and secondary bile acids.
    Hayes JD; Mantle TJ
    Biochem J; 1986 Jan; 233(2):407-15. PubMed ID: 3954743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates.
    Cowen AE; Korman MG; Hofmann AF; Cass OW
    Gastroenterology; 1975 Jul; 69(1):59-66. PubMed ID: 1150035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.
    Allan RN; Thistle JL; Hofmann AF; Carter JA; Yu PY
    Gut; 1976 Jun; 17(6):405-12. PubMed ID: 955495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.
    Cowen AE; Korman MG; Hofmann AF; Cass OW; Coffin SB
    Gastroenterology; 1975 Jul; 69(1):67-76. PubMed ID: 1097294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
    Stiehl A; Raedsch R; Kommerell B
    Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.